Home/Filings/4/0001127602-13-005626
4//SEC Filing

ZAMBROWICZ BRIAN P 4

Accession 0001127602-13-005626

CIK 0001062822other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:11 PM ET

Size

7.6 KB

Accession

0001127602-13-005626

Insider Transaction Report

Form 4
Period: 2013-02-08
ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units (Phantom Stock)

    2013-02-08+80,00080,000 total
    Common Stock (80,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2013-02-08+320,000320,000 total
    Exercise: $2.09Exp: 2023-02-08Common Stock (320,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years
  • [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2014) and vests 1/48th per month for each month of service thereafter

Issuer

LEXICON PHARMACEUTICALS, INC./DE

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001226231

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:11 PM ET
Size
7.6 KB